Sign In

Alina Charter

Global Director, Market Access, Pricing, HEOR and RWE

Dr. Alina Charter is a pharmaceutical executive with expertise in market access, commercial operations, and rare disease policy.46 She currently serves as the Vice President of Market Access and Policy at Alnylam Pharmaceuticals.2 Dr. Charter has extensive experience in the pharmaceutical industry, with expertise across over 20 therapeutic areas in oncology and pharma.4

Career Highlights

  • Current Role: Vice President, Market Access and Policy at Alnylam Pharmaceuticals2
  • Previous Experience: Senior Health Economics and Market Access Manager at AstraZeneca Canada1
  • Leadership: Leads teams and drives innovative market access strategies4
  • Recruitment: Involved in recruiting for executive-level positions in the pharmaceutical industry3

Expertise and Interests

  • Specializes in rare disease policy and advocates for holistic care approaches6
  • Champions patients' access to treatments5
  • Focuses on innovative market access strategies and early access programs3

Education and Location

  • Holds a DVM (Doctor of Veterinary Medicine) and MSc degree1
  • Education includes studies at SDA Bocconi4
  • Based in Basel, Switzerland4

Dr. Charter is active on LinkedIn, frequently sharing insights on pharmaceutical industry trends, rare disease policy, and market access strategies.567

Related Questions

What are Dr. Alina Charter's main responsibilities at AstraZeneca?
How has Dr. Alina Charter contributed to rare disease policy?
What is Dr. Alina Charter's background in oncology and pharma?
What teams has Dr. Alina Charter led in her career?
What are Dr. Alina Charter's key achievements at Alnylam Pharmaceuticals?
Alina Charter
Alina Charter, photo 1
Alina Charter, photo 2
Add to my network

Location

Basel Area, Switzerland